INSMED Inc Quarterly Deferred Income Tax Expense (Benefit) in USD from Q1 2016 to Q1 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
INSMED Inc quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2016 to Q1 2024.
- INSMED Inc Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $0.000.
- INSMED Inc annual Deferred Income Tax Expense (Benefit) for 2023 was -$54K, a 76.6% increase from 2022.
- INSMED Inc annual Deferred Income Tax Expense (Benefit) for 2022 was -$231K, a 93.3% increase from 2021.
- INSMED Inc annual Deferred Income Tax Expense (Benefit) for 2021 was -$3.45M.
Deferred Income Tax Expense (Benefit), Trailing 12 Months (USD)
Deferred Income Tax Expense (Benefit), Quarterly (USD)